Stay updated with breaking news from Multiple Sclerosis Progression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roche's Elecsys NfL test is intended to be used as an aid in detection of disease activity in adults with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis.
COVID-19 has no impact on disease activity, progression, or cognitive performance in patients with multiple sclerosis.
Smoking has been linked to more rapid MS progression and greater disease severity but new data suggest oral tobacco use tied to slower disease progression.
"Serious infections did not vary by age, and there were too few serious events to identify any age-related trends by specific TEAE," the authors reported.
A new study examined the prevalence of multiple sclerosis in different ethnic and racial groups and found that the disease is becoming more racially diverse.